IRIS UniCatt

Bria, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.329
AS - Asia 5.180
EU - Europa 3.219
SA - Sud America 1.303
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 15.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.143
SG - Singapore 2.336
BR - Brasile 1.094
CN - Cina 945
VN - Vietnam 717
IT - Italia 699
SE - Svezia 664
FR - Francia 373
DE - Germania 356
IN - India 315
GB - Regno Unito 186
IE - Irlanda 186
PL - Polonia 186
ID - Indonesia 156
FI - Finlandia 147
JP - Giappone 136
HK - Hong Kong 130
RU - Federazione Russa 92
AR - Argentina 87
BD - Bangladesh 82
MX - Messico 74
CA - Canada 68
IQ - Iraq 66
NL - Olanda 57
KR - Corea 52
ES - Italia 43
AT - Austria 41
TR - Turchia 40
ZA - Sudafrica 38
EC - Ecuador 33
UA - Ucraina 32
CI - Costa d'Avorio 31
PK - Pakistan 28
CO - Colombia 24
IR - Iran 24
VE - Venezuela 23
BE - Belgio 22
CZ - Repubblica Ceca 22
SA - Arabia Saudita 21
UZ - Uzbekistan 19
LT - Lituania 18
EG - Egitto 16
CH - Svizzera 14
KE - Kenya 14
TN - Tunisia 14
PY - Paraguay 13
JO - Giordania 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
IL - Israele 11
PH - Filippine 11
AL - Albania 9
DZ - Algeria 9
NP - Nepal 9
PT - Portogallo 9
RO - Romania 9
AZ - Azerbaigian 8
BO - Bolivia 8
HU - Ungheria 8
JM - Giamaica 8
AU - Australia 7
CR - Costa Rica 7
BG - Bulgaria 6
KZ - Kazakistan 6
LV - Lettonia 6
TW - Taiwan 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
LB - Libano 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
LU - Lussemburgo 4
PA - Panama 4
PE - Perù 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
GD - Grenada 2
GE - Georgia 2
GG - Guernsey 2
HR - Croazia 2
MY - Malesia 2
PS - Palestinian Territory 2
Totale 15.167
Salva come PNG Salva come JPEG
Città #
Singapore 1.286
Ashburn 622
Chandler 550
San Jose 545
Ho Chi Minh City 237
Beijing 221
Rome 194
Dublin 178
New York 178
Hanoi 177
Warsaw 172
Fairfield 163
Hyderabad 156
Hefei 139
Lauterbourg 136
Los Angeles 134
Tokyo 133
Council Bluffs 126
Jakarta 123
Hong Kong 116
The Dalles 116
Frankfurt am Main 104
Wilmington 103
São Paulo 102
Chicago 100
Houston 95
Milan 91
Princeton 91
San Mateo 84
Helsinki 82
Seattle 77
Munich 76
Dallas 68
Boston 67
Moscow 57
Woodbridge 57
Seoul 50
Cambridge 48
London 45
St Louis 45
Ann Arbor 43
Cattolica 43
Santa Clara 43
Marseille 40
Paris 40
Boardman 39
Orem 39
Kent 38
Buffalo 34
Turku 34
Abidjan 31
Lappeenranta 31
Chennai 30
Da Nang 30
Bremen 29
Haiphong 29
Rio de Janeiro 29
Denver 28
Nuremberg 28
Atlanta 26
Düsseldorf 26
Brooklyn 25
Redwood City 25
Poplar 24
Dearborn 23
Mexico City 23
Nanjing 23
Stockholm 23
Johannesburg 22
Brussels 21
Montreal 21
Curitiba 20
Goiânia 20
North Bergen 20
Hải Dương 19
Phoenix 19
Vienna 19
Amsterdam 18
Campinas 18
Manchester 18
Salt Lake City 18
San Francisco 18
Augusta 17
Dhaka 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Jacksonville 16
Andover 15
Guangzhou 15
Porto Alegre 15
Brno 14
Quito 14
Redmond 14
Riyadh 14
Hangzhou 13
Kish 13
Madrid 13
Norwalk 13
Querétaro 13
Totale 8.556
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 342
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 246
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 220
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 197
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 184
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 171
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 170
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 163
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 160
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 159
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 157
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 154
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series 151
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 150
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 150
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 149
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 147
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 144
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 144
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 143
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 140
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 140
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 139
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 138
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 135
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 133
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 133
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 133
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 132
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 132
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 132
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 130
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 128
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 128
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 126
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study 125
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 124
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 124
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 124
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 123
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy? 120
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 118
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 118
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 118
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 117
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 116
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 116
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 115
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 115
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 113
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial 112
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 112
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 111
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 109
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 109
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 108
Exploring the molecular and biological background of lung neuroendocrine tumours 107
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 107
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 106
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 106
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: The crucial role of histological type, number of resected nodes and adjuvant therapy 105
Nutritional Support in Lung Cancer Patients: The State of the Art 105
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 105
Collagenous colitis and atezolizumab therapy: an atypical case. 105
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 104
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 104
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 103
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 103
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 103
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 103
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 103
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 99
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 99
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 99
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 97
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 96
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 96
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 95
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 95
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 93
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 92
PTEN in colorectal cancer: Shedding light on its role as predictor and target 92
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 91
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer 91
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 90
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 89
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 87
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 87
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 86
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 82
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 82
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 80
ALK gene copy number gains in non-small-cell lung cancer: Prognostic impact and clinico-pathological correlations 80
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 80
Muscle derangement and alteration of the nutritional machinery in NSCLC 80
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 79
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature 79
Totale 12.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 44 62 26
2021/2022914 107 39 18 101 37 38 23 139 48 27 157 180
2022/20231.699 266 207 134 241 75 201 99 125 176 57 67 51
2023/20241.055 36 250 39 49 41 114 108 53 17 56 128 164
2024/20253.079 88 42 204 99 177 80 152 117 460 453 639 568
2025/20267.642 1.016 324 606 1.286 1.288 359 1.278 408 560 517 0 0
Totale 15.483